Pekka Ronka - Revenio Independent Director

REG1V Stock  EUR 26.42  0.62  2.40%   

Director

Mr. Pekka Ronka was Independent Chairman of the Board of Revenio Group Oyj since March 20, 2018. He was Independent Member of the Board of Directors of Revenio Group Oyj since March 20, 2014. Pekka Ronko currently acts as Chairman of the Board of Directors of HLD Healthy Life Devices Oy and Magnasense Technologies Oy. He has previously been, among other, Vice President and General Manager in Thermo Fisher Scientific . Earlier he has held the position of Vice President in Labsystems Oy. He holds a MS degree in Engineering. since 2018.
Tenure 6 years
Phone358 9877 51150
Webhttps://www.reveniogroup.fi

Revenio Management Efficiency

The company has return on total asset (ROA) of 0.1424 % which means that it generated a profit of $0.1424 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2575 %, meaning that it generated $0.2575 on every $100 dollars invested by stockholders. Revenio's management efficiency ratios could be used to measure how well Revenio manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Johanna LamminenSampo Oyj A
52
Gunilla NordstromWartsila Oyj Abp
57
Markus RauramoWartsila Oyj Abp
50
Adine GrateAxenSampo Oyj A
55
Tom JohnstoneWartsila Oyj Abp
63
Risto MurtoWartsila Oyj Abp
55
Sari KoluWartsila Oyj Abp
51
VeliMatti MattilaSampo Oyj A
57
Sune CarlssonWartsila Oyj Abp
75
Karin FalkWartsila Oyj Abp
53
Antti MakinenSampo Oyj A
57
Maarit AarniSirvioWartsila Oyj Abp
65
Natalia ValtasaariWartsila Oyj Abp
34
Adine AxenSampo Oyj A
57
Johan ForssellWartsila Oyj Abp
47
Christian ClausenSampo Oyj A
63
Fiona ClutterbuckSampo Oyj A
60
Risto MurtoSampo Oyj A
55
Per SorlieSampo Oyj A
60
Marko VainikkaWartsila Oyj Abp
48
Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments used for measuring intraocular pressure and bone density in Finland and rest of Europe, and internationally. The company serves general practitioners, opticians, optometrists, first-aid staff, and the field workers of aid organizations, as well as health care personnel working with child patients and in the vet clinics. Revenio Group operates under Medical Equipment classification in Finland and is traded on Helsinki Exchange. It employs 53 people. Revenio Group (REG1V) is traded on Helsinki Exchange in Finland and employs 207 people.

Management Performance

Revenio Group Leadership Team

Elected by the shareholders, the Revenio's board of directors comprises two types of representatives: Revenio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Revenio. The board's role is to monitor Revenio's management team and ensure that shareholders' interests are well served. Revenio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Revenio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Juha Kujala, S board
Ari Kohonen, Independent Director
OlliPekka Salovaara, President CEO, Member of the Management Team, Segment Director of Revenio Health Tech
Timo Hilden, CEO of Icare Finland Oy, CEO of Revenio Research Oy, Member of the Management Team
Ari Kukkonen, Icare Finland's Research & Development Director, Member of the Management Team
AnnChristine Sundell, Director
John Floyd, CEO of Icare USA
MBA MSc, VP Marketing
Pekka Ronka, Independent Director
Rolf Fryckman, Independent Director
Tiina Olkkonen, External Communications Specialist, Member of the Management Team
Pekka Tammela, Independent Chairman of the Board
Tomi Karvo, Icare Finland's Sales and Marketing Director, Member of the Management Team
Ari Isomki, VP Operations
Mika Salkola, Revenio Research Oy's R&D Director, Member of the Group Management Team
Heli Valtanen, Icare Finland Ltd's QA Manager, Member of the Group Management Team
Hanna Vuornos, VP Culture
Robin Pulkkinen, CFO, Member of the Management Team
Kyosti Kakkonen, Independent Director
MSc MSc, Chief Officer
Ari Isomaki, Icare Finland Ltd's Operations Director, Member of the Management Team,

Revenio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Revenio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Revenio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Revenio's short interest history, or implied volatility extrapolated from Revenio options trading.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revenio Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Revenio Stock analysis

When running Revenio's price analysis, check to measure Revenio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revenio is operating at the current time. Most of Revenio's value examination focuses on studying past and present price action to predict the probability of Revenio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revenio's price. Additionally, you may evaluate how the addition of Revenio to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Please note, there is a significant difference between Revenio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revenio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revenio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.